Acumen Pharmaceuticals, Inc. (ABOS)
Market Closed
12 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
2. 12
+0.16
+8.16%
$
118.12M Market Cap
- P/E Ratio
0% Div Yield
265,989 Volume
- Eps
$ 1.96
Previous Close Day Range
2 2.19
Year Range
0.85 2.46
Want to track ABOS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| ABOS Acumen Pharmaceuticals, Inc. 17 Nov 2025 | | - | - |
| ABOS Acumen Pharmaceuticals, Inc. 12 Nov 2025 | | - | - |
| ABOS Acumen Pharmaceuticals, Inc. 11 Nov 2025 | | - | - |
| ABOS Acumen Pharmaceuticals, Inc. 10 Nov 2025 | | - | - |
| ABOS Acumen Pharmaceuticals, Inc. 18 Aug 2025 | | - | - |
| ABOS Acumen Pharmaceuticals, Inc. 12 May 2025 | | - | - |
| ABOS Acumen Pharmaceuticals, Inc. 24 Mar 2025 | | - | - |
| ABOS Acumen Pharmaceuticals, Inc. 13 Nov 2024 | | - | - |
| ABOS Acumen Pharmaceuticals, Inc. 8 Aug 2024 | | - | - |
| ABOS Acumen Pharmaceuticals, Inc. 4 Jun 2024 | | - | - |
| ABOS Acumen Pharmaceuticals, Inc. 14 May 2024 | | - | - |
| ABOS Acumen Pharmaceuticals, Inc. 25 Mar 2024 | | - | - |
| ABOS Acumen Pharmaceuticals, Inc. 13 Nov 2023 | | - | - |
ABOS Earnings Reports FAQ
What is the earnings per share (EPS) for ABOS?
EPS data for ABOS is currently not available, as Acumen Pharmaceuticals, Inc has not reported recent earnings.
What is the company's earnings growth rate?
Acumen Pharmaceuticals, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Acumen Pharmaceuticals, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Acumen Pharmaceuticals, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ABOS at this time, as Acumen Pharmaceuticals, Inc has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
